Kiladjian JJ, Marin FF, Al-Ali HK, Alvarez-Larran A, Beggiato E, Bieniaszewska M, Breccia M, Buxhofer-Ausch V, Cerna O, Crisan AM, Danaila CD, De Stefano V, Dohner K, Empson V, Gora-Tybor J, Griesshammer M, Grosicki S, Guglielmelli P, Garcia-Gutierrez V, Heidel FH, Illes A, Tomuleasa C, James C, Koschmieder S, Krauth MT, Krejcy K, Lazaroiu MC, Mayer J, Nagy ZG, Nicolini FE, Palandri F, Pappa V, Reiter AJ, Sacha T, Schlager S, Schmidt S, Terpos E, Unger M, Wolfler A, Cirici BX, Klade C. ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options. Ann Hematol. 2024 Jul;103(7):2299-2310. doi: 10.1007/s00277-024-05665-4. Epub 2024 Mar 4. PubMed PMID: 38438627; PubMed Central PMCID: PMC11224110.
AÑO: 2024; IF: 3.0
|
Pastor-Galan I, Pereira A, Arellano-Rodrigo E, Martin I, Mosquera-Orgueira A, Gomez-Casares MT, Hernandez-Sanchez A, Ferrer-Marin F, Mora E, Velez P, Ayala R, Angona A, de Las Heras N, Magro E, Mata-Vazquez MI, Fox ML, Gonzalez de Villambrosia S, Ramirez MJ, Garcia A, Garcia-Gutierrez V, Caceres A, Duran MA, Senin MA, Raya JM, Gonzalez JA, Cuevas B, Xicoy B, Garrote M, Ferrer B, Perez-Encinas M, Hernandez-Rivas JM, Bellosillo B, Alvarez-Larran A, Hernandez-Boluda JC. Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis. Leukemia. 2024 Nov;38(11):2483-2486. doi: 10.1038/s41375-024-02389-2. Epub 2024 Aug 30. No abstract available. PubMed PMID: 39215061.
AÑO: 2024; IF: 12.8
|
Roldan V, Soler-Espejo E, Marin F. Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved. Thromb Haemost. 2024 Apr;124(4):337-339. doi: 10.1055/s-0043-1775582. Epub 2023 Sep 11. No abstract available. PubMed PMID: 37696302.
AÑO: 2024; IF: 5.0
|
Liu ZJ, Thom C, Nitulescu II, Pelish HE, Rimsza LM, Teruel-Montoya R, Ferrer-Marin F, Shair MD, Sola-Visner M. CDK8/19 inhibition triggers a switch from mitosis to endomitosis in cord blood megakaryocytes. Br J Haematol. 2024 Dec;205(6):2481-2486. doi: 10.1111/bjh.19836. Epub 2024 Oct 16. PubMed PMID: 39413769; PubMed Central PMCID: PMC11637730.
AÑO: 2024; IF: 5.1
|
Alvarez-Larran A, Cuevas B, Velez P, Noya S, Caballero-Navarro G, Ferrer-Marin F, Carbonell S, Perez-Encinas M, Gomez-Casares MT, Perez-Lopez R, Magro E, Moreto A, Pastor-Galan I, Angona A, Mata-Vazquez MI, Guerrero-Fernandez L, Guerra JM, Carreno-Tarragona G, Fox L, Murillo I, Garcia-Gutierrez V, Mora E, Stuckey R, Arellano-Rodrigo E, Hernandez-Boluda JC, Pereira A. Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia. Hemasphere. 2023 Jul 18;7(8):e936. doi: 10.1097/HS9.0000000000000936. eCollection 2023 Aug. PubMed PMID: 37476303; PubMed Central PMCID: PMC10356121.
AÑO: 2023; IF: 7.6
|